BlackRock Health Sciences Opportunities Portfolio Investor A Shares (SHSAX)

Fund Assets	6.09B
Expense Ratio	1.09%
Min. Investment	$1,000
Turnover	43.00%
Dividend (ttm)	0.19
Dividend Yield	0.29%
Dividend Growth	27.14%
Payout Frequency	Semi-Annual
Ex-Dividend Date	Jul 22, 2026

Previous Close	67.00
YTD Return	13.63%
1-Year Return	30.52%
5-Year Return	34.74%
52-Week Low	58.70
52-Week High	69.81
Beta (5Y)	0.69
Holdings	159
Inception Date	Dec 21, 1999

About SHSAX

BlackRock Health Sciences Opportunities Fund, Investor A is a mutual fund focused on delivering long-term capital growth by investing primarily in equities within the health sciences sector. It allocates at least 80% of its assets to common stocks of companies engaged in healthcare and related industries, including health care equipment and supplies, biotechnology, pharmaceuticals, and health care providers and services. The fund emphasizes innovation and scientific expertise in its investment approach, offering diversified exposure to both domestic and non-U.S. companies in the healthcare field. With a portfolio that balances growth potential and risk management, it targets diversified returns with lower volatility. The fund is noted for its broad coverage across large-cap health sciences companies, holding around 145 stocks, and has received a Morningstar Bronze Medal for its risk-adjusted performance. Its position within the health sector makes it a significant vehicle for investors seeking concentrated exposure to innovative healthcare equities while benefiting from BlackRock’s investment management capabilities.

• Fund Family: BlackRock
• Category: Health
• Performance Rating: Above Average
• Risk Rating: Low
• Stock Exchange: NASDAQ
• Ticker Symbol: SHSAX
• Share Class: Investor A
• Index: Russell 3000 Healthcare TR

Performance

SHSAX had a total return of 30.52% in the past year, including dividends. Since the fund's inception, the average annual return has been 13.36%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
SHSSX	Institutional	0.84%
SHISX	Service	1.14%
SHSCX	Investor C	1.86%

Top 10 Holdings

53.00% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	12.68%
Johnson & Johnson	JNJ	7.87%
UnitedHealth Group Incorporated	UNH	6.34%
Merck & Co., Inc.	MRK	5.26%
AbbVie Inc.	ABBV	5.11%
Gilead Sciences, Inc.	GILD	3.74%
Amgen Inc.	AMGN	3.44%
Thermo Fisher Scientific Inc.	TMO	3.18%
Vertex Pharmaceuticals Incorporated	VRTX	2.89%
Edwards Lifesciences Corporation	EW	2.49%

Dividend History

Ex-Dividend	Amount	Pay Date
Jul 22, 2026	$6.46449	Jul 23, 2026
Dec 9, 2025	$3.04694	Dec 10, 2025
Jul 17, 2025	$3.83665	Jul 18, 2025
Dec 11, 2024	$3.2425	Dec 12, 2024
Jul 18, 2024	$2.49135	Jul 19, 2024
Dec 7, 2023	$1.17094	Dec 8, 2023

Data Sources: Tiingo, Financial Modeling Prep, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Aug 27, 2026

Data Sources Report a data error